From Seekingalpha · · 30s
Exelixis Presents at Healthcare Innovation Conference
Exelixis shares strategy for zanza drug as it transitions from cabo to future healthcare focus.
In brief
Exelixis shares strategy for zanza drug as it transitions from cabo to future healthcare focus. Exelixis describes shifting from cabo to zanza as its long-term healthcare strategy. Originally reported by Seekingalpha.
Exelixis Strategy Update
Exelixis presents its transition from cabo to zanza as the long-term healthcare focus.
Third Annual Conference
Exelixis shares third annual guggenheim healthcare innovation conference presentation details.
Zanza Drug Focus
Exelixis highlights zanza as the future healthcare solution after cabo's 2020s role.
In short
Exelixis describes shifting from cabo to zanza as its long-term healthcare strategy.
